Skip to content

Personalis, Inc. PSNL Shares (Basic)

Shares (Basic) at other companies

NeoGenomics logo
NeoGenomicsNEO
129.2M+1.4%
Illumina logo
IlluminaILMN
153M-3.8%
Veracyte logo
VeracyteVCYT
79.5M+1.9%
Guardant Health logo
Guardant HealthGH
131.3M+6.0%
Natera, Inc. logo
Natera, Inc.NTRA
141.5M+5.0%
Quest Diagnostics logo
Quest DiagnosticsDGX

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.19B+110%
Enterprise value$1.16B+115%
P/S18.4×+11.8×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Reported directly by Personalis, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Personalis, Inc.'s shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Personalis, Inc.'s shares (basic)?
Personalis, Inc. (PSNL) reported shares (basic) of 104.2M in Q1 2026.
How has Personalis, Inc.'s shares (basic) changed year-over-year?
Personalis, Inc.'s shares (basic) increased by 19.1% year-over-year, from 87.5M to 104.2M.
What is the long-term trend for Personalis, Inc.'s shares (basic)?
Over 3 years (2022 to 2025), Personalis, Inc.'s shares (basic) has grown at a 24.8% compound annual growth rate (CAGR), from 182.3M to 353.9M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.